New Delhi, Jul 11 (PTI) Shares of Glenmark Pharmaceuticals Ltd ended 14.51 per cent higher on Friday after the firm announced signing an up to USD 2-billion deal with AbbVie to commmercialise its ...

Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...

AbbVie has entered into a $1 billion licensing agreement with IGI Therapeutics SA, for IGI's lead investigational drug for ...

The Europe Pharmaceutical Drugs Market size is valued at USD 450 billion in 2025 and is expected to reach USD 610 billion by ...

The funding will be deployed over a three-year period from 2025 to 2027, enabling Alfasigma to significantly advance its R&D ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

Across our campus and throughout our nearly 400 years, Harvard innovation—in medicine, technology, education, and beyond—has ...

Recent restructuring efforts at the Food and Drug Administration may have been well-intentioned, but they risk undermining the very innovation and domestic capacity the president seeks to promote.

Recent restructuring efforts at the Food and Drug Administration may have been well-intentioned, but they risk undermining the very innovation and domestic capacity the president seeks to promote.

These differentiated offerings expand upon IDT’s current infectious disease portfolio of qPCR and next generation sequencing (NGS) solutions comprised of stand-alone library preparation, target ...